Cargando…
Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report
Small cell lung cancer (SCLC) is a highly aggressive malignancy with a poor outcome. We present the case of a 57-year-old male patient with extensive-stage (ES-SCLC) treated with chemotherapy and atezolizumab. A complete response was achieved with a long remission of ∼three years. Comprehensive geno...
Autores principales: | Tomic, Kresimir, Karan Krizanac, Dragana, Skenderi, Faruk, Krpina, Kristina, Carapina Bilic, Andrea, Galic, Kristina, Gatalica, Zoran, Vranic, Semir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558768/ https://www.ncbi.nlm.nih.gov/pubmed/37810185 http://dx.doi.org/10.1016/j.rmcr.2023.101920 |
Ejemplares similares
-
Acinic cell carcinoma of the breast: A comprehensive review
por: Ajkunic, Azra, et al.
Publicado: (2022) -
Small Cell Lung Carcinoma: Current Diagnosis, Biomarkers, and Treatment Options with Future Perspectives
por: Krpina, Kristina, et al.
Publicado: (2023) -
HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome
por: Skenderi, Faruk, et al.
Publicado: (2022) -
TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors
por: Kruslin, Bozo, et al.
Publicado: (2021) -
Novel targetable biomarkers in clear cell carcinoma of the breast uncovered by molecular profiling: A study of nine cases
por: Skenderi, Faruk, et al.
Publicado: (2020)